Skip to main content

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

May 2013 - FRMC

05/17/2013
San Diego—The emerging model for healthcare in the United States is value-driven healthcare, according to speakers at a Contemporary Issues session at the AMCP meeting. The session was titled How Much of the $3 Billion in Star Rating Bonuses...
San Diego—The emerging model for healthcare in the United States is value-driven healthcare, according to speakers at a Contemporary Issues session at the AMCP meeting. The session was titled How Much of the $3 Billion in Star Rating Bonuses...
San Diego—The emerging model for...
05/17/2013
First Report Managed Care
05/17/2013
San Diego—Despite clinical practice that usually does not include the introduction of insulin therapy in patients newly diagnosed with type 2 diabetes mellitus (T2DM), most patients will eventually require treatment with insulin to maintain...
San Diego—Despite clinical practice that usually does not include the introduction of insulin therapy in patients newly diagnosed with type 2 diabetes mellitus (T2DM), most patients will eventually require treatment with insulin to maintain...
San Diego—Despite clinical...
05/17/2013
First Report Managed Care
05/17/2013
San Diego—The challenges that come with the launch of the new health insurance marketplaces as 2014 rapidly approaches were topic for discussion in a Contemporary Issues session at the AMCP meeting titled Fostering Healthy Markets:...
San Diego—The challenges that come with the launch of the new health insurance marketplaces as 2014 rapidly approaches were topic for discussion in a Contemporary Issues session at the AMCP meeting titled Fostering Healthy Markets:...
San Diego—The challenges that...
05/17/2013
First Report Managed Care
05/17/2013
San Diego—Many companies that supply insulin can offer products with similar pharmacokinetic or pharmacodynamic (PK/PD) properties. This is the case with the active ingredients of insulin products produced by Eli Lilly and Company (LLY) and...
San Diego—Many companies that supply insulin can offer products with similar pharmacokinetic or pharmacodynamic (PK/PD) properties. This is the case with the active ingredients of insulin products produced by Eli Lilly and Company (LLY) and...
San Diego—Many companies that...
05/17/2013
First Report Managed Care
05/17/2013
San Diego—The best time for a physician and patient to decide on an effective, comprehensive, and manageable treatment plan is during the initial prescribing visit. This is, according to a Contemporary Issues session at the AMCP meeting, the...
San Diego—The best time for a physician and patient to decide on an effective, comprehensive, and manageable treatment plan is during the initial prescribing visit. This is, according to a Contemporary Issues session at the AMCP meeting, the...
San Diego—The best time for a...
05/17/2013
First Report Managed Care
05/17/2013
San Diego—The cost of care has significantly increased for Medicare patients taking leucovorin and/or Fusilev® (levoleucovorin) since the first leucovorin shortage in 2008, according to findings from a recent retrospective analysis presented...
San Diego—The cost of care has significantly increased for Medicare patients taking leucovorin and/or Fusilev® (levoleucovorin) since the first leucovorin shortage in 2008, according to findings from a recent retrospective analysis presented...
San Diego—The cost of care has...
05/17/2013
First Report Managed Care
05/17/2013
San Diego—An understanding of the current usage patterns of infliximab in the treatment of rheumatoid arthritis (RA) is a crucial component in the management of patients. Because real-world data of weight-based utilization patterns of this...
San Diego—An understanding of the current usage patterns of infliximab in the treatment of rheumatoid arthritis (RA) is a crucial component in the management of patients. Because real-world data of weight-based utilization patterns of this...
San Diego—An understanding of...
05/17/2013
First Report Managed Care
05/17/2013
San Diego—Engaging patients and improving medication adherence was the aim of a program implemented in a population of dual-eligible special needs Medicare Advantage (MA) beneficiaries. The program involved the cooperation of a MA plan...
San Diego—Engaging patients and improving medication adherence was the aim of a program implemented in a population of dual-eligible special needs Medicare Advantage (MA) beneficiaries. The program involved the cooperation of a MA plan...
San Diego—Engaging patients and...
05/17/2013
First Report Managed Care
05/17/2013
Based on a new claims-based algorithm developed to evaluate the effectiveness of biologics for rheumatoid arthritis (RA), self-injected subcutaneous (SC) first-line biologic agents are more effective than intravenous (IV) administered agents...
Based on a new claims-based algorithm developed to evaluate the effectiveness of biologics for rheumatoid arthritis (RA), self-injected subcutaneous (SC) first-line biologic agents are more effective than intravenous (IV) administered agents...
Based on a new claims-based...
05/17/2013
First Report Managed Care

Department

Conference Insider
05/17/2013
San Diego—The Medicaid patient population is expected to grow under the Patient Protection and Affordable Care Act (ACA), leaving managed care organizations (MCOs) to face increasing challenges as they attempt to limit costs, particularly in...
San Diego—The Medicaid patient population is expected to grow under the Patient Protection and Affordable Care Act (ACA), leaving managed care organizations (MCOs) to face increasing challenges as they attempt to limit costs, particularly in...
San Diego—The Medicaid patient...
05/17/2013
First Report Managed Care

Advertisement

Advertisement

Advertisement